Literature DB >> 19493067

Developing nations and the compulsory license: maximizing access to essential medicines while minimizing investment side effects.

Robert C Bird1.   

Abstract

This manuscript addresses how developing countries can maximize access to essential medicines and minimize unwanted side-effects within the legal environment of a compulsory license regime. While compulsory licensing can play a role in improving public health, external social and political conditions must be considered in order to make licensing an effective practice.

Mesh:

Substances:

Year:  2009        PMID: 19493067     DOI: 10.1111/j.1748-720X.2009.00366.x

Source DB:  PubMed          Journal:  J Law Med Ethics        ISSN: 1073-1105            Impact factor:   1.718


  5 in total

Review 1.  Access to medications and conducting clinical trials in LMICs.

Authors:  Ikechi G Okpechi; Charles R Swanepoel; Francois Venter
Journal:  Nat Rev Nephrol       Date:  2015-02-10       Impact factor: 28.314

Review 2.  Access to cancer medications in low- and middle-income countries.

Authors:  Gilberto de Lima Lopes; Jonas A de Souza; Carlos Barrios
Journal:  Nat Rev Clin Oncol       Date:  2013-04-09       Impact factor: 66.675

3.  Ethical Overview of Pharmaceutical Industry Policies in Turkey from Various Perspectives.

Authors:  Murat Oral; Gülbin Özçelikay
Journal:  Turk J Pharm Sci       Date:  2017-11-20

4.  Importance of the intellectual property system in attempting compulsory licensing of pharmaceuticals: a cross-sectional analysis.

Authors:  Kyung-Bok Son
Journal:  Global Health       Date:  2019-06-27       Impact factor: 4.185

5.  The Legislative Approach and System Improvement of China's Compulsory Licensing for Drug Patents.

Authors:  Zhang Cao; Yichao Chen; Wenjie Jiang; Wei Li
Journal:  Drug Des Devel Ther       Date:  2021-09-01       Impact factor: 4.162

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.